the allstate corp. - ALL
ALL
Close Chg Chg %
194.66 -1.09 -0.56%
Open Market
193.58
-1.09 (0.56%)
Volume: 71.01K
Last Updated:
Jul 11, 2025, 10:06 AM EDT
Company Overview: the allstate corp. - ALL
ALL Key Data
| Open $193.67 | Day Range 192.34 - 193.99 |
| 52 Week Range 158.04 - 213.18 | Market Cap $51.40B |
| Shares Outstanding 264.82M | Public Float 263.21M |
| Beta 0.33 | Rev. Per Employee N/A |
| P/E Ratio 13.26 | EPS $14.82 |
| Yield 197.85% | Dividend $1.00 |
| EX-DIVIDEND DATE Jun 9, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.78M |
ALL Performance
| 1 Week | -1.97% | ||
| 1 Month | -2.43% | ||
| 3 Months | 0.80% | ||
| 1 Year | 18.57% | ||
| 5 Years | 123.17% |
ALL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 233.25 | |
| Number of Ratings | 22 | Current Quarters Estimate | 4.366 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 18.136 | |
| Last Quarter’s Earnings | 3.244 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 18.32 | Next Fiscal Year Estimate | 21.638 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 17 | 17 | 21 | 20 |
| Mean Estimate | 4.37 | 6.85 | 18.14 | 21.64 |
| High Estimates | 5.34 | 7.94 | 20.30 | 25.85 |
| Low Estimate | 2.93 | 5.66 | 15.05 | 19.51 |
| Coefficient of Variance | 13.98 | 10.04 | 6.82 | 6.93 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 17 | 17 | 17 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 3 | 3 | 4 |
| UNDERWEIGHT | 0 | 0 | 1 |
| SELL | 2 | 2 | 2 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for The Allstate Corp. - ALL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for The Allstate Corp. - ALL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 8, 2025 | Mario Rizzo | 18,578 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 8, 2025 | Mario Rizzo | 68,704 | Bona fide gift | 0.00 |
| May 8, 2025 | Mario Rizzo | 70,504 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $200.64 per share | 14,145,922.56 |
| May 8, 2025 | Mario Rizzo | 74,722 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $92.8 per share | 6,934,201.60 |
| Apr 4, 2025 | Perry Marques Traquina Director | 4,984 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $207.5 per share | 1,034,180.00 |
| Apr 4, 2025 | Margaret M. Keane Director | 14,610 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $207.5 per share | 3,031,575.00 |
| Feb 27, 2025 | Eric K. Ferren SVP, Controller, and CAO | 665 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Suren K. Gupta | 2,040 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Suren K. Gupta | 7,934 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Christine M. DeBiase EVP, CLO and General Counsel | 8,500 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Christine M. DeBiase EVP, CLO and General Counsel | 2,185 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Mark Prindiville | 1,208 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | John Edward Dugenske | 12,055 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | John Edward Dugenske | 3,099 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 93,349 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 63,004 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $189.52 per share | 11,940,518.08 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 63,104 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $188.79 per share | 11,913,404.16 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 70,876 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $188.03 per share | 13,326,814.28 |
| Feb 27, 2025 | Thomas Joseph Wilson Chairman, President & CEO; Director | 92,947 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $186.83 per share | 17,365,288.01 |
| Feb 27, 2025 | Eric K. Ferren SVP, Controller, and CAO | 1,726 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
The Allstate Corp. in the News
Allstate requests 34% hike on insurance in California as state's insurance crisis escalates: report
Allstate is looking to raise insurance rates for some California customers by 34% as the insurance giant weighs its future in the Golden State.
Allstate to revive Dean Winters' Mayhem character
Allstate is reportedly set to revive Dean Winters' Mayhem character over a year after going silent on the character.